What are the causes of delayed pain after an intramuscular (IM) injection in adult and adolescent patients, considering factors such as injection technique, medication type and volume, and patient's individual response, including those with a history of bleeding disorders or taking anticoagulant medications?

Causes of Delayed Pain After Intramuscular Injection

Delayed pain after intramuscular injection is most commonly caused by local tissue reaction to the medication, injection technique factors, or medication-specific properties, with the most frequent being injection-site soreness from tissue trauma and inflammatory response to the injectate. 1, 2

Primary Causes of Delayed Pain

Local Tissue Reaction and Inflammation

• Injection-site soreness is the most common delayed adverse event, occurring in approximately 13% of patients (17 of 132 patients with follow-up data in one study), typically developing hours after injection rather than immediately. 1
• Local tissue trauma from needle insertion and medication deposition triggers an inflammatory cascade that peaks 6-24 hours post-injection. 2
• The volume and pH of the injected medication directly correlate with tissue irritation—larger volumes and medications with extreme pH values cause more tissue distention and chemical irritation. 2

Medication-Specific Factors

• Corticosteroid injections specifically cause delayed facial flushing and sweating in some patients, representing a systemic absorption effect rather than local tissue reaction. 1
• Propofol causes pain on injection when administered through peripheral veins, though this is typically immediate rather than delayed. 1
• The chemical composition and osmolality of the medication determine the degree of tissue irritation—hypertonic solutions cause more pain than isotonic formulations. 3

Injection Technique-Related Causes

• Slow injection speed with aspiration causes significantly more pain than rapid injection without aspiration (standardized mean difference of -0.62 to -0.97 across multiple pain scales). 4
• Subcutaneous or intramuscular injections have wider fluctuations in absorption and more rapid fall-off of action than oral routes, potentially causing localized tissue reactions. 1
• The rate of drug administration affects pain intensity—slower administration allows more time for tissue distention and irritation. 5

Less Common but Important Causes

Infectious Complications

• Abscess formation or cellulitis presents with delayed pain accompanied by erythema, warmth, swelling, or induration at the injection site, though these are rare complications. 2
• Joint infection following intra-articular injection has been reported in case reports, presenting with progressive pain days after injection. 1
• More serious infections including spinal epidural abscess, meningitis, and endocarditis have occurred in immunosuppressed patients, though these are exceedingly rare. 1

Vascular and Nerve-Related Causes

• Transient nerve block from anterior capsular disruption (particularly sciatic nerve) can occur with certain injection sites, causing delayed neurologic symptoms and associated pain. 1
• Hematoma formation in patients with bleeding disorders or on anticoagulants can cause delayed, progressive pain as the hematoma expands. 2

Pain Exacerbation

• Pain exacerbations occurred in 5% of patients (7 of 132) in one study, representing worsening of pre-existing pain conditions rather than new-onset pain. 1

Critical Distinguishing Features

Timing Patterns

• Pain occurring 5-15 minutes post-injection typically represents a normal pharmacologic response to tissue distention. 2
• Pain developing hours to days later suggests local tissue reaction, inflammatory response, or complications requiring further evaluation. 2

Red Flag Symptoms Requiring Escalation

• Fever, hypotension, or signs of systemic allergic reaction indicate potential serious complications beyond simple injection-site pain. 2
• Progressive swelling, erythema, warmth, or induration suggest infectious complications requiring antibiotic therapy. 2

Important Clinical Pitfalls

• Never administer additional intramuscular injections to treat IM injection pain—this is specifically contraindicated and will worsen tissue trauma and inflammation. 2
• Do not dismiss delayed pain as purely psychological—referred muscle pain can occur from the primary injection site and depends on ongoing noxious inputs from that site. 3
• Avoid assuming all delayed pain is benign—systematic assessment for infection, hematoma, or nerve injury is essential when pain persists beyond 48 hours or worsens progressively. 2